SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1907Short answer=No. At current interest rates, SNY (and most large companies) can bDewDiligence_on_SI-4/28/2016
1906RE: AMGN Repatha patents Delayed thought on this issue, ...blind was able to seMiljenko Zuanic-4/28/2016
1905IF SNY is going with all-cash aqu. of the MDNV (let say ~$12-14B), would it needMiljenko Zuanic-4/28/2016
1904Interesting for REGN: stm.sciencemag.org ABBV is paying $10.2B for Stemcentrx oMiljenko Zuanic-4/28/2016
1903Interesting: communityoncology.orgMiljenko Zuanic-4/27/2016
19021Q: <Bayer registered considerably higher sales (Fx adj. plus 48.9 percent) oMiljenko Zuanic-4/26/2016
1901Projecting Eylea 1Q sale based on Lucentis performance, going up! In contradictMiljenko Zuanic-4/21/2016
1900They have to show that Avastin/Fovista is cheaper, more convenient, and more effMiljenko Zuanic-4/16/2016
1899Thoughts on Opthotech?Felix B-4/15/2016
1898It is too early to make any expectation. At this point it is technology platformMiljenko Zuanic-4/14/2016
1897What therapeutics to you expect to come out of this/CRISPR, I am not too verse iFelix B-4/13/2016
1896Nice to see some ADC news, seems like the other day SGEN/IMGN were all the rage Felix B-4/13/2016
1895Intellia deal, investor.regeneron.com This is not something new to them, they haMiljenko Zuanic-4/11/2016
1894<Is MedImmunes proven?> I think that it is not, in reality...do not know.Miljenko Zuanic-4/7/2016
1893I am not too familiar with ADC technology but curious why they chose them over oFelix B-4/7/2016
1892Boost in efficacy by PBD (from the bi-specific perspective) definitely would beMiljenko Zuanic-4/5/2016
1891It appears that REGN thinks a boost in efficacy in several approaches may be neeBiotech Jim-4/5/2016
1890<Maybe I need to re-visit SGEN and their patent applications!> As I thougMiljenko Zuanic-4/5/2016
1889files.shareholder.com Regeneron diving into ADCs! Can ADC be incorporated into Miljenko Zuanic-4/5/2016
1888<<As to valuations and which specific drug or testing program is going to Miljenko Zuanic-4/1/2016
1887REGN is one of the leaders in the industry, so if their stock is weak, it makes The Ox-4/1/2016
1886Results are as good as expected, push toward other indications and higher WS priMiljenko Zuanic-4/1/2016
1885Regeneron, Sanofi eczema drug clears hurdles in big trials APRIL 1 | BY RANSDELThe Ox-4/1/2016
1884Let me make record straight, ….I feel that way. Otherwise I may implode/explMiljenko Zuanic33/29/2016
1883IF documents show that SNY/REGN did not try to settle patents infringements by &Miljenko Zuanic-3/23/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News